Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
Jan 5, 2026, 4:00 PM EST
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $138.27 thousand as of January 7, 2026. Its market cap has decreased by -99.28% in one year.
Market Cap
138.27K
Enterprise Value
149.88K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 5, 2014, Nascent Biotech's market cap has decreased from 16.24M to 138.27K, a decrease of -99.15%. That is a compound annual growth rate of -34.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 138.27K | 33.33% |
| Dec 31, 2025 | 103.71K | -98.81% |
| Dec 31, 2024 | 8.74M | -69.97% |
| Dec 29, 2023 | 29.11M | 19.95% |
| Dec 30, 2022 | 24.27M | 341.66% |
| Dec 31, 2021 | 5.49M | 37.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |